TY - STD TI - EPHI, HIV Related Estimates and Projections for Ethiopia–2017. Ethiopian Public Health Institute. March 2017, Addis Ababa 2017. ID - ref1 ER - TY - JOUR AU - Assefa, Y. PY - 2014 DA - 2014// TI - Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013 JO - Glob Health VL - 10 UR - https://doi.org/10.1186/1744-8603-10-43 DO - 10.1186/1744-8603-10-43 ID - Assefa2014 ER - TY - STD TI - Gilks C, Vitoria M, And World Health Organization. Dept. of HIV/AIDS., Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 rev. ed. Geneva: World Health Organization; 2006. p. 128. ID - ref3 ER - TY - STD TI - HAPCO. Guidelines for Management of Opportunistic Infections and Anti-retroviral Treatment in Adolescents and Adults in Ethiopia. 2008. Available at: https://www.who.int/hiv/pub/guidelines/ethiopia_art.pdf. Accessed 31 May 2016. UR - https://www.who.int/hiv/pub/guidelines/ethiopia_art.pdf ID - ref4 ER - TY - STD TI - UNAIDS. UNAIDS DATA 2017. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2017. ID - ref5 ER - TY - STD TI - HAPCO, Report on progress towards implementation of the UN declaration of commitment on HIV/AIDS, Federal Democratic Republic of Ethiopia, federal HIV/AIDS prevention and control office, Addis Ababa, Ethiopia. 2010. ID - ref6 ER - TY - STD TI - HAPCO. Country progress report on HIV/AIDS response, Federal Democratic Republic of Ethiopia, Federal HIV/AIDS Prevention and Control Office, Addis Ababa, Ethiopia April 2012. Federal HAPCO; 2012. ID - ref7 ER - TY - JOUR AU - Hamers, R. L. PY - 2013 DA - 2013// TI - Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa JO - Curr Opin HIV AIDS VL - 8 UR - https://doi.org/10.1097/COH.0b013e32835b7f94 DO - 10.1097/COH.0b013e32835b7f94 ID - Hamers2013 ER - TY - JOUR AU - Mulu, A. AU - Maier, M. AU - Liebert, U. G. PY - 2015 DA - 2015// TI - Low incidence of HIV-1C acquired drug resistance 10 years after roll-out of antiretroviral therapy in Ethiopia: a prospective cohort study JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0141318 DO - 10.1371/journal.pone.0141318 ID - Mulu2015 ER - TY - JOUR AU - Abdissa, A. PY - 2014 DA - 2014// TI - Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia JO - BMC Infect Dis VL - 14 UR - https://doi.org/10.1186/1471-2334-14-181 DO - 10.1186/1471-2334-14-181 ID - Abdissa2014 ER - TY - JOUR AU - Mulu, A. AU - Maier, M. AU - Liebert, U. G. PY - 2017 DA - 2017// TI - Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: a decade longitudinal study JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0186619 DO - 10.1371/journal.pone.0186619 ID - Mulu2017 ER - TY - JOUR AU - Tadesse, B. i. r. k. n. e. h. AU - Kinloch, N. a. t. a. l. i. e. AU - Baraki, B. e. m. u. l. u. y. i. g. z. a. AU - Lapointe, H. o. p. e. AU - Cobarrubias, K. y. l. e. AU - Brockman, M. a. r. k. AU - Brumme, C. h. a. n. s. o. n. AU - Foster, B. y. r. o. n. AU - Jerene, D. e. g. u. AU - Makonnen, E. y. a. s. u. AU - Aklillu, E. l. e. n. i. AU - Brumme, Z. a. b. r. i. n. a. PY - 2018 DA - 2018// TI - High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia JO - Viruses VL - 10 UR - https://doi.org/10.3390/v10020060 DO - 10.3390/v10020060 ID - Tadesse2018 ER - TY - STD TI - Kalu AW, et al. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort. BMC Infect Dis, 2017;17(1):37. ID - ref13 ER - TY - JOUR AU - Telele, N. F. PY - 2018 DA - 2018// TI - Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of sanger and high-throughput sequencing JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-25888-6 DO - 10.1038/s41598-018-25888-6 ID - Telele2018 ER - TY - JOUR AU - Lindstrom, A. AU - Albert, J. PY - 2003 DA - 2003// TI - A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1 JO - J Virol Methods VL - 107 UR - https://doi.org/10.1016/S0166-0934(02)00188-X DO - 10.1016/S0166-0934(02)00188-X ID - Lindstrom2003 ER - TY - JOUR AU - Wensing, A. M. PY - 2017 DA - 2017// TI - Update of the drug resistance mutations in HIV-1 JO - Top Antivir Med, 2017 VL - 24 ID - Wensing2017 ER - TY - JOUR AU - Amogne, W. PY - 2016 DA - 2016// TI - Phylogenetic analysis of Ethiopian HIV-1 subtype C near full-length genomes reveals high Intrasubtype diversity and a strong geographical cluster JO - AIDS Res Hum Retrovir VL - 32 UR - https://doi.org/10.1089/aid.2015.0380 DO - 10.1089/aid.2015.0380 ID - Amogne2016 ER - TY - STD TI - Grossmann S, Nowak P, Neogi U. Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management. J Int AIDS Soc. 2015;18. ID - ref18 ER - TY - JOUR AU - Huang, X. AU - Madan, A. PY - 1999 DA - 1999// TI - CAP3: a DNA sequence assembly program JO - Genome Res VL - 9 UR - https://doi.org/10.1101/gr.9.9.868 DO - 10.1101/gr.9.9.868 ID - Huang1999 ER - TY - JOUR AU - Salminen, M. O. PY - 1996 DA - 1996// TI - Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C JO - AIDS Res Hum Retrovir VL - 12 UR - https://doi.org/10.1089/aid.1996.12.1329 DO - 10.1089/aid.1996.12.1329 ID - Salminen1996 ER - TY - JOUR AU - Larsson, A. PY - 2014 DA - 2014// TI - AliView: a fast and lightweight alignment viewer and editor for large datasets JO - Bioinformatics VL - 30 UR - https://doi.org/10.1093/bioinformatics/btu531 DO - 10.1093/bioinformatics/btu531 ID - Larsson2014 ER - TY - JOUR AU - Gabadinho, A. PY - 2011 DA - 2011// TI - Analyzing and visualizing state sequences in R with TraMineR JO - J Stat Softw VL - 40 UR - https://doi.org/10.18637/jss.v040.i04 DO - 10.18637/jss.v040.i04 ID - Gabadinho2011 ER - TY - BOOK PY - 2014 DA - 2014// TI - A language and environment for statistical computing PB - R Foundation for Statistical Computing CY - Vienna, Austria ID - ref23 ER - TY - JOUR AU - Vandekerckhove, L. P. PY - 2011 DA - 2011// TI - European guidelines on the clinical management of HIV-1 tropism testing JO - Lancet Infect Dis VL - 11 UR - https://doi.org/10.1016/S1473-3099(10)70319-4 DO - 10.1016/S1473-3099(10)70319-4 ID - Vandekerckhove2011 ER - TY - STD TI - DHHS. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Laboratory testing; plasma HIV-1 RNA (viral load) and CD4 count monitoring. Last updated: may 1, 2014; last reviewed: may 1, 2014. U.S. Department of Health & Human Services; 2018. Available at: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/458/plasma-hiv-1-rna--viral-load--and-cd4-count-monitoring. Accessed 10 May 2018. UR - https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/458/plasma-hiv-1-rna%2D%2Dviral-load%2D%2Dand-cd4-count-monitoring ID - ref25 ER - TY - STD TI - WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach - Second edition. 2016. Available at: http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 10 June 2018. UR - http://www.who.int/hiv/pub/arv/arv-2016/en/ ID - ref26 ER - TY - JOUR AU - Havlir, D. V. PY - 2001 DA - 2001// TI - Prevalence and predictive value of intermittent viremia with combination HIV therapy JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.2.171 DO - 10.1001/jama.286.2.171 ID - Havlir2001 ER - TY - JOUR AU - Kityo, C. i. s. s. y. AU - Szubert, A. l. e. x. a. n. d. e. r. J. AU - Siika, A. b. r. a. h. a. m. AU - Heyderman, R. o. b. e. r. t. AU - Bwakura-Dangarembizi, M. u. t. s. a. AU - Lugemwa, A. b. b. a. s. AU - Mwaringa, S. h. a. l. t. o. n. AU - Griffiths, A. n. n. a. AU - Nkanya, I. m. m. a. c. u. l. a. t. e. AU - Kabahenda, S. h. e. i. l. a. AU - Wachira, S. i. m. o. n. AU - Musoro, G. o. d. f. r. e. y. AU - Rajapakse, C. h. a. t. u. AU - Etyang, T. i. m. o. t. h. y. AU - Abach, J. a. m. e. s. AU - Spyer, M. o. i. r. a. J. AU - Wavamunno, P. r. i. s. c. i. l. l. a. AU - Nyondo-Mipando, L. i. n. d. a. AU - Chidziva, E. n. n. i. e. AU - Nathoo, K. u. s. u. m. AU - Klein, N. i. g. e. l. AU - Hakim, J. a. m. e. s. AU - Gibb, D. i. a. n. a. M. AU - Walker, A. S. a. r. a. h. AU - Pett, S. a. r. a. h. L. PY - 2018 DA - 2018// TI - Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial JO - PLOS Medicine VL - 15 UR - https://doi.org/10.1371/journal.pmed.1002706 DO - 10.1371/journal.pmed.1002706 ID - Kityo2018 ER - TY - JOUR AU - Ryscavage, P. PY - 2014 DA - 2014// TI - Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.00076-14 DO - 10.1128/AAC.00076-14 ID - Ryscavage2014 ER - TY - JOUR AU - Nettles, R. E. PY - 2004 DA - 2004// TI - Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/423388 DO - 10.1086/423388 ID - Nettles2004 ER - TY - JOUR AU - Haas, A. n. d. r. e. a. s. D. AU - Zaniewski, E. l. i. z. a. b. e. t. h. AU - Anderegg, N. a. n. i. n. a. AU - Ford, N. a. t. h. a. n. AU - Fox, M. a. t. t. h. e. w. P. AU - Vinikoor, M. i. c. h. a. e. l. AU - Dabis, F. r. a. n. ç. o. i. s. AU - Nash, D. e. n. i. s. AU - Sinayobye, J. e. a. n. d. '. A. m. o. u. r. AU - Niyongabo, T. h. ê. o. d. o. r. e. AU - Tanon, A. r. i. s. t. o. p. h. a. n. e. AU - Poda, A. r. m. e. l. AU - Adedimeji, A. d. e. b. o. l. a. A. AU - Edmonds, A. n. d. r. e. w. AU - Davies, M. a. r. y. -. A. n. n. AU - Egger, M. a. t. t. h. i. a. s. PY - 2018 DA - 2018// TI - Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes JO - Journal of the International AIDS Society VL - 21 UR - https://doi.org/10.1002/jia2.25084 DO - 10.1002/jia2.25084 ID - Haas2018 ER - TY - JOUR AU - Brenner, B. G. PY - 2006 DA - 2006// TI - HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000232228.88511.0b DO - 10.1097/01.aids.0000232228.88511.0b ID - Brenner2006 ER - TY - JOUR AU - Coutsinos, D. PY - 2011 DA - 2011// TI - A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1 JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0020208 DO - 10.1371/journal.pone.0020208 ID - Coutsinos2011 ER - TY - STD TI - van Tienen C, et al. Letter to the editor: pre-exposure prophylaxis for HIV in Europe: the need for resistance surveillance. Euro Surveill. 2017;22(11). ID - ref34 ER - TY - STD TI - World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach - 2010 revision. 2010 rev. ed. Geneva: World Health Organization; 2010. p. 145. ID - ref35 ER - TY - JOUR AU - Velen, K. PY - 2013 DA - 2013// TI - Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0064459 DO - 10.1371/journal.pone.0064459 ID - Velen2013 ER - TY - JOUR AU - Neogi, U. PY - 2018 DA - 2018// TI - Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes JO - AIDS VL - 32 ID - Neogi2018 ER - TY - JOUR AU - Neogi, U. PY - 2016 DA - 2016// TI - Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkv359 DO - 10.1093/jac/dkv359 ID - Neogi2016 ER - TY - STD TI - Gulick RM, Flexner C. Long-acting HIV drugs for treatment and prevention. Annu Rev Med. 2018. ID - ref39 ER - TY - JOUR AU - Pillay, S. K. PY - 2014 DA - 2014// TI - Gag drug resistance mutations in HIV-1 subtype C patients, failing a protease inhibitor inclusive treatment regimen, with detectable lopinavir levels JO - J Int AIDS Soc VL - 17 UR - https://doi.org/10.7448/IAS.17.4.19784 DO - 10.7448/IAS.17.4.19784 ID - Pillay2014 ER - TY - JOUR AU - Su, Y. PY - 2015 DA - 2015// TI - Mechanism of HIV-1 resistance to short-peptide fusion inhibitors targeting the Gp41 pocket JO - J Virol VL - 89 UR - https://doi.org/10.1128/JVI.00373-15 DO - 10.1128/JVI.00373-15 ID - Su2015 ER - TY - JOUR AU - Neogi, U. PY - 2014 DA - 2014// TI - Novel tetra-peptide insertion in gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients JO - AIDS VL - 28 UR - https://doi.org/10.1097/QAD.0000000000000419 DO - 10.1097/QAD.0000000000000419 ID - Neogi2014 ER - TY - JOUR AU - Martins, A. N. PY - 2011 DA - 2011// TI - Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients JO - AIDS Res Hum Retrovir VL - 27 UR - https://doi.org/10.1089/aid.2010.0282 DO - 10.1089/aid.2010.0282 ID - Martins2011 ER - TY - JOUR AU - Sharma, S. PY - 2017 DA - 2017// TI - The PTAP sequence duplication in HIV-1 subtype C gag p6 in drug-naive subjects of India and South Africa JO - BMC Infect Dis VL - 17 UR - https://doi.org/10.1186/s12879-017-2184-4 DO - 10.1186/s12879-017-2184-4 ID - Sharma2017 ER - TY - STD TI - Wijting IEA, et al. HIV-1 resistance dynamics in patients failing dolutegravir maintenance monotherapy. J Infect Dis. 2018. ID - ref45 ER - TY - JOUR AU - Johansson, B. AU - Sherefa, K. AU - Sonnerborg, A. PY - 1995 DA - 1995// TI - Multiple enhancer motifs in HIV type 1 strains from Ethiopia JO - AIDS Res Hum Retrovir VL - 11 UR - https://doi.org/10.1089/aid.1995.11.761 DO - 10.1089/aid.1995.11.761 ID - Johansson1995 ER -